Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
9 papers
Recent·Most cited
H. K. Elias, S. Mitra, M. B. da Silva, A. Rajagopalan, B. Gipson, N. Lee, A. I. Kousa, M. A. E. Ali, S. Grassman, X. Zhang, S. DeWolf, M. Smith, H. Andrlova, K. V. Argyropoulos, R. Sharma, , M. R. M. van den Brink
This study identifies an epigenetically distinct HSC subset, Kitlo, that supports better thymic and T-cell reconstitution in mice and humans.
bioRxiv · Jun 6, 2024 · PreprintImmunology
C. Zhong, W.-J. Jiang, Y. Yao, Z. Li, Y. Li, S. Wang, X. Wang, W. Zhu, S. Wu, J. Wang, S. Fan, S. Ma, Y. Liu, H. Zhang, W. Zhao, , T. Fei
This study identifies convergent therapeutic targets for chemoresistance in cancer using CRISPR screens across multiple drug conditions and cancer models.
bioRxiv · Apr 24, 2024Cancer Biology
Y. Wang, A. Mao, J. Liu, P. Li, S. Zheng, T. Tong, Z. Li, H. Zhang, L. Ma, J. Lin, Z. Pang, Q. Han, F. Li, X. Zhang, M. Chen, , R. Sheng
This study identifies USP10 as a novel regulator of β-catenin through dual mechanisms involving deubiquitination and phase separation, with implications for cancer treatment.
Cell Chemical Biology · Nov 1, 2023Peer-reviewedCell Biology
B. Singh, N. Dopkins, T. Fei, J. L. Marston, S. Michael, H. Reyes-Gopar, G. Curty, J. J. Heymann, A. Chadburn, P. Martin, F. E. Leal, E. Cesarman, D. F. Nixon, M. L. Bendall
The paper identifies unique HERV signatures in B-cell lymphoma subtypes that can improve classification and diagnosis when combined with gene expression.
bioRxiv · Jun 8, 2023Cancer Biology
Y. Yao, Y. Zhang, Z. Li, Z. Chen, X. Wang, Z. Li, L. Yu, X. Cheng, W. Li, W.-J. Jiang, H.-J. Wu, Z. Feng, J. Sun, T. Fei
This study uses deep learning to screen FDA-approved drugs and TCM compounds for anti-SARS-CoV-2 activity by targeting cell entry, identifying several effective candidates.
bioRxiv · Jun 3, 2023Microbiology
M. Abate, T. Fei, Y.-H. Lin, S. Shimada, H. Drebin, E. Chen, L. Tang, V. E. Strong, S. A. Vardhana
This study uses high-dimensional spectral cytometry to identify immune subtypes in gastric cancer, finding that certain subtypes correlate with better responses to immunotherapy.
bioRxiv · Mar 29, 2023 · PreprintCancer Biology
C. Liao, T. Rolling, A. Djukovic, T. Fei, V. Mishra, H. Liu, C. Lindberg, L. Dai, B. Zhai, J. U. Peled, M. R. M. van den Brink, T. M. Hohl, J. B. Xavier
The paper investigates the association between oral bacteria in feces and gut microbiota depletion, supporting the Marker hypothesis over the Expansion hypothesis.
bioRxiv · Oct 24, 2022Microbiology
A. Chen, Y. Sun, Y. Lei, C. Li, S. Liao, Z. Liang, F. Lin, N. Yuan, M. Li, K. Wang, M. Yang, S. Zhang, Z. Zhuang, J. Meng, Q. Song, , Zhang
The paper creates a 3-D cell type atlas of the monkey brain using single-cell spatial transcriptomics and identifies molecular markers for neocortical layers and subregions.
bioRxiv · Mar 23, 2022Cell Biology
Y. LIAO, C.-H. Chen, N. Shah, T. Xiao, A. Feit, M. Yang, C. Cai, S. Gao, P. Xue, Z. Liu, H. Xu, J. Lee, W. Li, S. Mei, R. S. Pierre, , K. Xu
This study shows EZH2 inhibitors inhibit CRPC growth by downregulating DNA repair genes, making cancer cells more sensitive to genotoxic stress.
bioRxiv · Sep 11, 2020 · PreprintCancer Biology